Related Experiment Video

Updated: May 9, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

10.8K

Roles of ABCA1 in Chronic Obstructive Pulmonary Disease

Ying Gu1, Xiaoqing Bi1, Xiaofei Liu1

  • 1Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.

COPD
|April 30, 2025
PubMed

Insights

ATP-binding cassette transporter A1 (ABCA1) is crucial in chronic obstructive pulmonary disease (COPD). This transporter regulates lipid metabolism and inflammation, suggesting ABCA1 as a potential therapeutic target for COPD.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Respiratory Medicine

Background:

  • Chronic obstructive pulmonary disease (COPD) poses a significant global health burden.
  • Emerging evidence highlights the role of ATP-binding cassette transporter A1 (ABCA1) in COPD pathogenesis.

Purpose of the Study:

  • To elucidate the multifaceted roles of ABCA1 in COPD.
  • To explore ABCA1 as a potential therapeutic target for COPD management.

Main Methods:

  • Review of existing literature on ABCA1 function and its involvement in COPD.
  • Analysis of ABCA1's participation in key cellular processes like cholesterol transport, apoptosis, pyroptosis, inflammation, and immunity.
  • Examination of ABCA1's role in relevant signaling pathways (SREBP, LXR, MAPK, p62/mTOR, CTRP1).

Main Results:

  • ABCA1 regulates lipid metabolism in COPD by influencing reverse cholesterol transport (RCT) and high-density lipoprotein (HDL) formation.
  • ABCA1 mitigates COPD-related inflammation by facilitating cholesterol efflux from macrophages.
  • ABCA1 activity is linked to the progression of COPD towards emphysema.

Conclusions:

  • ABCA1 plays a critical role in the pathophysiology of COPD, affecting lipid metabolism and inflammation.
  • Targeting ABCA1 presents a promising therapeutic strategy for treating chronic obstructive pulmonary disease.

Keywords:
ABCA1COPDapoptosiscellular immunitycellular inflammationinflammationpyroptosissignal transduction

More Related Videos

Cholesterol Efflux Assay07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

29.7K
Author Spotlight: A Bicelle Crystallization Setup for ABC Transporter Membrane Proteins to Advance Drug Development06:47

Author Spotlight: A Bicelle Crystallization Setup for ABC Transporter Membrane Proteins to Advance Drug Development

Published on: August 25, 2023

1.2K

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.1K
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
2.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K